|4Mar 19, 7:29 PM ET

Craig Kevin James 4

4 · ATAI Life Sciences N.V. · Filed Mar 19, 2025

Insider Transaction Report

Form 4
Period: 2025-03-14
Craig Kevin James
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2025-03-14+20,00020,000 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-1420,0000 total
    Common Shares (20,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. The restricted stock units vested on March 14, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4